Alpine Immune Sciences, Inc. ALPN
Set alert
64.97 0.00 0.00%
At close · May 17
64.97 Day range 65.00
52-week range unavailable
- Open
- 64.98
- Prev close
- 64.97
- Mkt cap
- 4.46B
- Vol
- 4.29M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 64.97
- High
- 65.00
- Forward P/E
- -32.48
- Beta
- 0.97
- Short ratio
- 0.96
- Inst. own
- 99.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 53.15
- 200-d avg
- 26.84
- 1y target
- 62.00
Analyst view
Consensus: buy
Buy
Price target (mean) 62.00 -4.6% downside
Now 64.97
- Target (low)
- 44.00
- Target (mean)
- 62.00
- Target (high)
- 65.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy2
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 9
- 2 months ago 8
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.42 | -0.50 – -0.35 | -0.27 | -55.6% | 0 | 0.0% | 2 |
| Next quarter | -0.42 | -0.49 – -0.36 | -0.24 | -75.0% | 0 | 0.0% | 2 |
| Current year | -1.55 | -1.77 – -1.34 | -0.64 | -142.2% | 15.50M | -73.7% | 2 |
| Next year | -2.00 | -2.35 – -1.65 | -1.55 | -29.0% | 8.00M | -48.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 17, 2023 | Berenberg | Initiated | — | Buy |
| Oct 4, 2023 | RBC Capital | Initiated | — | Outperform |
| Sep 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 10, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 31, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 30, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Aug 14, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 23, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Jan 18, 2023 | Morgan Stanley | Initiated | — | Overweight |
| Nov 20, 2022 | SVB Leerink | Initiated | — | Outperform |
| Oct 24, 2022 | Oppenheimer | Maintained | — | Outperform |
| Dec 20, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 25, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Aug 11, 2020 | Piper Sandler | Maintained | — | Overweight |
| Sep 26, 2018 | Piper Sandler | Initiated | — | Overweight |
| Jun 28, 2018 | Oppenheimer | Initiated | — | Outperform |
| May 17, 2018 | Wedbush | Initiated | — | Outperform |
| Sep 21, 2017 | Stifel | Upgrade | Hold | Buy |
| Jul 26, 2017 | Ladenburg Thalmann | Initiated | — | Buy |